Advancing Medicine
Through Spray
Innovation
Malta-based EU GMP manufacturer delivering next-generation spray formulations for cardiovascular, migraine, and nutraceutical therapies across EU and MENA markets.
Redefining Pharmaceutical
Delivery Systems
AxionPharm Limited is a Malta-based EU GMP pharmaceutical manufacturer with a clear mission: to bring innovative spray-based medicines to patients across Europe, the Middle East, and North Africa. Our approach combines cutting-edge formulation science with rigorous regulatory compliance to deliver products that outperform conventional oral dosage forms.
Founded with a commitment to advancing healthcare, AxionPharm delivers strategic value to Malta by creating skilled employment, strengthening the local pharmaceutical ecosystem, boosting export revenues, and advancing environmental sustainability.
Building 102, Hal Far Industrial Zone
Malta · EU GMP Production Facility
EU GMP Certified
Fully compliant with EU Good Manufacturing Practice standards. Registered with Malta Business Registry (Reg. C111466, March 2025).
Export-Oriented Strategy
Targeting EU distributor networks, MENA tender markets, direct specialist supply, and trade partnerships across key growth regions.
Spray-Based Innovation
Pioneering spray formulations that deliver superior bioavailability, faster onset of action, and improved patient adherence.
State-of-the-Art Facility
~2,500 m² total site in Malta's Hal Far industrial zone — 550 m² GMP production, 300 m² GDP warehouse, 1,650 m² offices & labs.
Therapeutic Areas
Four high-value areas where spray-based delivery provides a clear clinical and commercial advantage over conventional dosage forms.
Cardiovascular Therapies
Spray-form delivery achieving rapid systemic absorption and superior bioavailability versus conventional oral formulations.
- Rapid systemic absorption via sublingual/buccal spray routes
- Superior bioavailability compared to conventional oral tablets
- High and consistent demand across EU, Middle East, and North Africa
- Targeting nitrate-based and antihypertensive formulations
- Reduced first-pass metabolism for improved efficacy
Target Markets
Interested in distribution or licensing partnerships?
Science-Driven Innovation
Our R&D capabilities combine deep formulation expertise with a pragmatic regulatory strategy to bring differentiated products to market efficiently.
Advanced Spray Formulation Technology
Our R&D team specialises in developing proprietary spray formulations that overcome the bioavailability limitations of conventional oral dosage forms. By leveraging sublingual, buccal, and nasal delivery routes, we achieve faster onset of action and superior therapeutic outcomes for patients.
- Sublingual & buccal spray platforms
- Nasal drug delivery systems
- Enhanced bioavailability formulations
- Stability and shelf-life optimisation
EU & MENA Regulatory Expertise
AxionPharm's regulatory team navigates the complex landscape of EU EMA guidelines and MENA country-specific requirements. Our dossier preparation and submission strategy is designed to accelerate market access while maintaining the highest standards of documentation and compliance.
- EU EMA dossier preparation
- MENA regulatory submissions
- CTD format documentation
- Post-approval change management
Proprietary Delivery Platforms
We are developing a portfolio of proprietary spray delivery platforms that can be applied across multiple therapeutic areas. These platforms provide a competitive moat, enabling faster product development cycles and reduced time-to-market for new formulations.
- Platform-based product development
- Reduced development timelines
- Scalable manufacturing processes
- IP protection strategy
Uncompromising
Quality Standards
Quality is not a department at AxionPharm — it is embedded in every process, every decision, and every product we manufacture. Our quality management system is built on EU GMP principles and continuously improved to meet evolving regulatory expectations.
EU GMP Certification
AxionPharm operates under full EU Good Manufacturing Practice guidelines, ensuring every product meets the stringent quality standards required for European market access.
GDP Compliant Warehousing
Our ~300 m² GDP-compliant warehouse ensures the integrity of pharmaceutical products throughout storage and distribution, maintaining cold chain and documentation requirements.
In-House Quality Control
Dedicated QC laboratories perform rigorous testing at every stage of production — from raw material release to finished product batch certification.
Multi-Market Regulatory Compliance
Our regulatory affairs team maintains compliance with EU EMA requirements and actively manages submissions across MENA markets including tender and direct supply channels.
Environmental Sustainability
AxionPharm is committed to sustainable manufacturing practices, minimising environmental impact through efficient processes and responsible resource management.
Qualified Personnel
Our team includes Qualified Persons (QPs), regulatory specialists, and experienced pharmaceutical scientists ensuring every batch meets release specifications.
Committed to Regulatory Excellence
AxionPharm maintains full transparency with regulatory authorities and partners. Our documentation, batch records, and quality systems are audit-ready at all times.
Build Your Career in
Pharmaceutical Innovation
AxionPharm is building a world-class team of pharmaceutical professionals in Malta. We are looking for passionate scientists, regulatory experts, and manufacturing specialists who want to make a real difference in patients' lives while working at the forefront of spray-based medicine technology.
Innovation First
We encourage bold thinking and reward creative problem-solving at every level.
Collaborative Culture
Cross-functional teams work together to bring products from concept to patient.
Growth Mindset
We invest in our people through training, mentorship, and career development.
Global Impact
Your work directly contributes to improving patient outcomes across two continents.
Interested in joining AxionPharm? We're always looking for exceptional pharmaceutical talent.
Contact
Us
Whether you're a distributor, licensing partner, investor, or potential employee — we'd love to hear from you. Reach out and our team will respond within 2 business days.
Company Registration
Reg. C111466 · Malta Business Registry
Registered March 2025